Orthopedic Devices Market

Orthopedic Devices Market Summary

• The global Orthopedic Devices  market size is projected to increase from USD 44.09 billion in 2023 to USD 57.79 billion by 2032, reflecting strong and sustained growth.
• The global Orthopedic Devices  market is expected to grow at a CAGR of 4.78% during the forecast period from 2025 to 2032. 
• The orthopedic devices market is set for growth due to an aging population, rising cases of osteoarthritis, osteoporosis, and injuries, along with advancements in medical technology.
• The leading companies working in the Orthopedic Devices market are Tryker Corporation, Zimmer Biomet, Johnson and Johnson, Enovis, Smith & Nephew PLC, Medtronic PLC, Boston Scientific Corporation, NuVasive Inc., Globus Medical Inc., ConMed Corporation, Bioventus, Orthofix, Colson Medical LLC, Exactech Inc., Medacta International, Surgalign Holdings, Paragon 28 Inc, Orthofix, Arthrex Inc., Seimens, Bosch Global, and others.
• North America is expected to lead the global orthopedic devices market in 2023, driven by a growing elderly population, rising cases of osteoarthritis, osteoporosis, and injuries. A large patient base and increasing demand have prompted key players to launch new products, further fueling market growth in the region.
• The spine segment is expected to witness notable revenue growth in the orthopedic devices market during the forecast period (2025–2032).

Request for unlocking the report of the Orthopedic Devices Market

Factors Contributing to the Rise in Growth of the Orthopedic Devices Market

• Rising Prevalence of Orthopedic Disorders:
  The increasing global incidence of orthopedic conditions, such as osteoarthritis, osteoporosis, fractures, and sports-related injuries, is driving demand for advanced orthopedic devices and implants.
• Growing Adoption of Orthopedic Devices:
  Rising awareness among patients and healthcare providers, combined with a preference for surgical interventions that restore mobility and quality of life, is fueling the adoption of orthopedic devices.
• Technological Advancements & Product Innovation:
  Continuous innovation in joint reconstruction, spinal implants, trauma fixation devices, and minimally invasive surgical tools is enhancing patient outcomes, recovery times, and procedural safety.
• Government & Healthcare Awareness Initiatives:
  Supportive health campaigns and public health initiatives promoting bone and joint health, early diagnosis, and access to surgical treatments are boosting demand for orthopedic solutions.
• Expanding Access in Emerging Markets:
  Increasing healthcare investments, improved access to orthopedic care, and growing acceptance of advanced medical technologies in developing regions are creating new opportunities for orthopedic device manufacturers.

Orthopedic Device Market Type By Product (Implants, Supports, and Others), Application (Knee, Hip, Wrist, Shoulder, Spine, and Others), End-User (Hospitals & Clinics, Ambulatory Surgical Centres, and Others), and Geography is estimated to register growth at a remarkable CAGR forecast during 2025-2032 owing to upsurge in prevalence of ageing population and rise in the cases of bone disorders. 

The global orthopedic devices market was valued at USD 44.09 billion in 2023, growing at a CAGR of 4.78% during the forecast period from 2025 to 2032 to reach USD 57.79 billion by 2032. The orthopedic devices market is slated to witness increasing revenue owing to factors such as a growing population of people above the age of 65, a rise in the cases of bone disorders such as osteoarthritis and osteoporosis among others, increasing cases of occupational injuries and non-occupational injuries along with latest technological developments in healthcare technology are further expected to result in the appreciable revenue growth in the orthopedic devices market during the forecast period (2025-2032).

Orthopedic Devices Market Dynamics:

One of the major factors influencing the growth of the orthopaedic medical devices market is increase in the prevalence of various types of bone disorders such as osteoarthritis, osteoporosis, among others, along with increase in the cases of joint pain globally.  According to World Health Organization (WHO) 2022, musculoskeletal conditions are the leading contributor to disability, and worldwide around 1.71 billion people are suffering from musculoskeletal diseases such as osteoporosis, osteoarthritis, rheumatoid arthritis, and others. Osteoarthritis, affects the joints and with time leads to the wearing off of smooth cartilage from the surface of bones. This causes patients to face inflammation, swelling, and pain in the joints affecting the overall movement of a person. In severe cases, patients undergo orthopaedic implant surgery. 

The US orthopedic devices market has been witnessing consistent growth driven by the rising prevalence of musculoskeletal disorders, an aging population, and advancements in medical technology. Increasing demand for joint reconstruction, spinal devices, trauma fixation, and minimally invasive surgical solutions has positioned the market as a crucial segment within the broader healthcare industry. Moreover, technological innovations such as 3D printing, robotics, and AI-assisted surgeries are reshaping treatment approaches, thereby expanding the opportunities in the orthopedics devices market.

In another report by the World Health Organization published in 2023?/span>, worldwide around 528 million people suffered from osteoarthritis in 2019. As per the same source, worldwide 18 million people had rheumatoid arthritis in 2019. The above-mentioned source further stated that osteoarthritis contributed to 19 million years lived with disability (YLDs), while rheumatoid arthritis contributed to 2.4 million YLDs globally in 2019. 

Thus, owing to the presence of a large patient population associated with bone disorders worldwide, the demand for orthopaedic medical devices in the form of implants, supports and others is expected to increase substantially in the upcoming years.Hence, the increasing number of joint pain cases and bone diseases globally is thereby anticipated to propel the overall market growth of the orthopaedic medical devices during the forecast period from 2023-2032. 

Another key factor responsible for the growth of the orthopedic devices market is the continuous technological advancements in manufacturing safe and biocompatible implants. For instance, in May 2021, Orthofix US Inc. launched OSCAR PRO for use in ultrasonic arthroplasty revision systems during complex joint surgeries, in the U.S and European markets. Such product development activities indicate an active research and development domain resulting in the launch of improved products in the market, contributing to product uptake and ultimately resulting in market growth.

With a strong presence of global leaders and emerging players, the US orthopedic devices market continues to remain highly competitive. Companies are investing in research and development to deliver innovative products that enhance patient outcomes and reduce recovery time. Additionally, the rising number of sports-related injuries and road accidents further fuels the demand across different segments of the orthopedics devices market, ensuring long-term growth and sustainability. However, the availability of alternative therapies and complications associated with orthopedic devices, specifically implants, may act as restraining factors to the orthopedic devices market growth.

Orthopedic Devices Market Segment Analysis:

Orthopedic devices Market Type By Product (Implants, Supports, and Others), Application (Knee, Hip, Wrist, Shoulder, Spine, and Others), End-User (Hospitals & Clinics, Ambulatory Surgical Centres, and Others), and Geography (North-America, Europe, Asia-Pacific, Rest of the World)

Based on the application segment of the orthopedic devices market the spine category is projected to register significant growth in revenue in the orthopedic devices market during the forecast period (2025-2032). This can be ascribed to the rising cases of spinal cord injuries for various reasons such as occupational work, overuse injuries, falls, wounds from fights, spinal injuries to athletes, and others.

According to the National Spinal Cord Injury Statistical Centre (2023) in the year 2019, 2,96,000 people were living with spinal cord injuries globally, with 17,900 new cases happening every year around the world. This brings the need for more assistance support mechanisms and efficient surgical procedures for people, which drives orthopedic industries to deliver safer, biocompatible implants for people on a lifetime basis.

Therefore, considering the growing demand for this product type, numerous new products are being launched in the market. For instance, in October 2020, Stryker Corporation introduced Niagra Lateral Access System for spinal injuries and deformities, after the completion of successful 600 surgeries. The implant is widely compatible with patients, allowing fewer chances of contamination and side effects, with a biocompatible titanium. Therefore, considering the advantages associated with spinal reconstruction devices and their growing popularity among end-users, this product segment is expected to generate considerable revenue thereby pushing the overall growth of the global orthopedic devices market during the forecast period.

Orthopedic Devices Market Segmentation

Orthopedic Devices Market By Product

• Implants

• Supports

• Others

Orthopedic Devices Market By Application

• Knee

• Hip

• Wrist

• Shoulder

• Spine

• Others

Orthopedic Devices Market By End-User

• Hospitals & Clinics

• Ambulatory Surgical Centres

• Others

Orthopedic Devices Market by Geography

North America Orthopedic Devices Market

• United States Orthopedic Devices Market

• Canada Orthopedic Devices Market

• Mexico Orthopedic Devices Market

Europe Orthopedic Devices Market

• France Orthopedic Devices Market

• Germany Orthopedic Devices Market

• United Kingdom Orthopedic Devices Market

• Italy Orthopedic Devices Market

• Spain Orthopedic Devices Market

• Russia Orthopedic Devices Market

• Rest of Europe

Asia-Pacific Orthopedic Devices Market

• China Orthopedic Devices Market

• Japan Orthopedic Devices Market

• India Orthopedic Devices Market

• Australia Orthopedic Devices Market

• South Korea Orthopedic Devices Market

• Rest of Asia Pacific

Rest of the World (RoW)

• Middle East Orthopedic Devices Market

• Africa Orthopedic Devices Market

• South America Orthopedic Devices Market

North America is expected to dominate the overall Orthopedic Devices Market:

Among all the regions, North America is expected to lead in revenue generation in the global orthopedic devices market. This can be ascribed to the growing population of old-aged people in the region. For instance, according to the U.S. Census Bureau (2022), the old age population observed an increase of 34.2%, from 40.3 million U.S. residents aged 65 years in the year 2010 to 54.1 million or older in the year 2019.

One of the prominent factors supporting the growth of the North America orthopedic devices market is the rising prevalence of bone disorders like osteoarthritis, osteoporosis, etc. For example, as per the CDC report (2023), more than 32.5 million people are affected by Osteoarthritis which is one of the most common forms of joint disorders in the United States. Along with the growing aged population, the risk of bone disorders also increases. For instance, according to the Osteoarthritis Action Alliance (2023), in the year 2019, 43% of people aged above 65 years and 88% of people aged above 45 years were diagnosed with Osteoarthritis. The source further stated that more than 60% of people affected were women. Considering the rising number of bone disorders in the country, numerous products are receiving regulatory approvals thus paving the way for their market launch. For instance, in May 2022, the U.S. Food and Drug Administration (FDA) approved the AccelStim Bone growth Stimulator, manufactured by Orthofix US LLC, which can be used in cases of bone fractures. Also, In September 2020, Stryker Corporation launched its titanium-made AxSOS Ankle Fusion System for the tibiotalar joint with updated screw offerings.

Therefore, the presence of a large patient base coupled with increasing cases of bone disorders drives manufacturers to launch new products, which is expected to drive the growth of the orthopedic devices market in the United States during the forecast period.

In addition to the rising old age population and cases of bone disorders, there has been an increase in the number of occupational injuries and non-occupational injuries in the United States. For example, according to the U.S Bureau of Labor Statistics (2023), an incidence rate of 25.4% of occupational injuries was observed of which 24% of injuries consisted of traumatic injuries in the year 2020. The source also stated that there were about 53,000 cases of injuries to the bone, cartilage, and tendons along with sprains, strains, and muscle tears, resulting from non-occupational reasons such as violence, abuse, and fights requiring implants and other assistance mechanisms. Therefore, such reasons coupled with a large patient pool having bone disorders and occupational injuries shall further drive the demand for orthopedic devices in the United States during the forecast period. 

Orthopedic Devices Market Key Players:

• Stryker Corporation
• Zimmer Biomet
• Johnson and Johnson
• Enovis
• Smith & Nephew PLC
• Medtronic PLC
• Boston Scientific Corporation
• NuVasive Inc.
• Globus Medical Inc.
• ConMed Corporation
• Bioventus
• Orthofix
• Colson Medical LLC
• Exactech Inc.
• Medacta International
• Surgalign Holdings
• Paragon 28 Inc
• Orthofix (duplicate)
• Arthrex Inc.
• Siemens (corrected spelling)
• Bosch Global

Recent Developmental Activities in the Orthopedic Devices Market:

• In May 2025, Hyalex Orthopaedics secured FDA approval of an IDE supplement, allowing expansion into a pivotal clinical trial for its Freestyle Knee Implant designed for cartilage repair in early osteoarthritis.
• In April 2025, Proprio received FDA 510(k) clearance for its Paradigm AI surgical guidance platform, enabling real-time 3D intraoperative visualization and measurement for spine and orthopedic surgeries.
• In April 2025, Medline UNITE obtained FDA 510(k) clearance for the REFLEX® HYBRID Nitinol Implant System, enhancing foot and ankle fixation surgery.
• In March 2025, Monogram Technologies received FDA 510(k) clearance for its mBôs™ Total Knee Arthroplasty (TKA) System and companion mPress implants, advancing its AI-driven orthopedic robotics platform
• In March 2025, Johnson & Johnson MedTech showcased innovations like the VELYS™ robotic-assisted knee system (approved for unicompartmental knee arthroplasty) and the VOLT™ plating system (CE mark and FDA 510(k) clearance) at AAOS 2025.
• In March 2025, Zimmer Biomet unveiled its Persona Revision Solution Femur, with U.S. availability expected in Q3 2025, expanding the company’s implantable solutions portfolio.
• In January 2025, OrthoPreserve received both FDA Breakthrough Device Designation and Total Product Life Cycle Advisory Program (TAP) enrollment for its Defender meniscus replacement implant, marking it one of the first orthopedic devices to gain TAP status.
• In May 2022, Orthofix US LLC got approval from the FDA for its orthopedic device AccelStim Bone Growth Stimulator in Texas, USA, which can be used in cases of bone fractures.
• In March 2022, Stryker launched the Insignia Hip stem, used for total hip stem arthroplasty and hemi-arthroplasty processes, at the American Academy of Orthopedic Surgeons Annual Meeting.
• In June 2021, Medtronic received FDA clearance for UNiD rods, screws, and fusion devices that uses Artificial Intelligence Technology for treating spinal injuries.

Key Orthopedic Devices Highlights Summary (2022–2025)

AI Advancement in Orthopedic Devices

• AI-Driven Surgical Planning: Advanced algorithms analyze patient imaging data (X-rays, CT, MRI) to create personalized surgical plans, enabling higher accuracy in implant placement and reducing revision rates.

• Robotics Integration: AI-powered robotic-assisted systems enhance precision during joint replacement, spine, and trauma surgeries, minimizing human error and improving long-term outcomes.

• Predictive Analytics & Patient Monitoring: AI models predict patient recovery trajectories, identify risks of implant failure or complications, and support tailored rehabilitation programs.

• Smart Implants & Sensors: Next-gen orthopedic implants are being integrated with AI-enabled biosensors that monitor real-time joint performance, load distribution, and healing progress, offering continuous feedback to physicians.

• Automated Imaging & Diagnostics: AI tools accelerate fracture detection, bone density analysis, and alignment assessment, reducing diagnostic delays and improving treatment planning.

• Digital Twins & Simulation Models: Virtual patient-specific simulations allow surgeons to rehearse complex orthopedic procedures, enhancing preparedness and optimizing surgical outcomes.

Tariff Inclusion in Orthopedic Devices

The imposition of tariffs on orthopedic devices and their components has introduced significant challenges across the healthcare supply chain. Rising import costs, coupled with manufacturing and sourcing disruptions, are reshaping pricing models and forcing companies to reassess strategic operations. For stakeholders in the orthopedic sector, understanding these tariff implications is critical to maintaining competitiveness, managing risks, and ensuring uninterrupted patient access to advanced orthopedic care.

How This Analysis Helps Clients

• Cost Management: Insights into tariff-driven cost increases enable stakeholders to adapt pricing models, safeguard margins, and ensure sustainable operations.

• Supply Chain Optimization: Identifying alternative suppliers and diversifying sourcing strategies reduces reliance on tariff-affected regions, improving supply chain resilience.

• Regulatory Navigation: Guidance on evolving trade regulations helps clients remain compliant and avoid penalties while adapting to shifting import-export dynamics.

• Strategic Planning: Clear visibility into tariff impacts supports informed decisions on manufacturing locations, partnerships, and long-term market entry strategies.

Startup Funding & Investment Trends in Orthopedic Devices

Key Takeaways from the Orthopedic Devices Market Report Study

• Market size analysis for current orthopedic device market size (2023), and market forecast for 5 years (2025-2032)
• The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Orthopedic Devices market.
• Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years
• Key companies dominating the global orthopedic devices market.
• Various opportunities available for the other competitor in the orthopedic device market space.
• What are the top-performing segments in 2023? How these segments will perform in 2032.
• Which are the top-performing regions and countries in the current orthopedic device market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for orthopedic devices market growth in the coming future?

Target Audience who can be benefited from this Orthopedic Devices Market Report Study

• Orthopedic Devices providers
• Research organizations and consulting companies
• Orthopedic device-related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and Traders dealing in drug-eluting stents
• Various end-users want to know more about the orthopedic device market and the latest technological developments in the orthopedic device market.

Frequently Asked Questions for Orthopedic Devices Market:

1. What are Orthopedic Devices?

Orthopedic devices can be defined as any device, physical support, or implant assisting the human body, mostly in the skeletal system to restore damaged bones, joints, ligaments, and other neighboring structures to recover primary functional locomotive abilities.

2. What is the market for Global Orthopedic Devices?

The global orthopedic devices market was valued at USD 44.09 billion in 2023, growing at a CAGR of 4.78% during the forecast period from 2025 to 2032 to reach USD 57.79 billion by 2032.

3. What are the drivers for the Global Orthopedic Devices market?

The orthopedic device market is expected to grow significantly owing to factors such as the growing prevalence of bone diseases such as osteoarthritis, osteoporosis, etc. The global rise in the old age population also will lead to an increase in the number of assistance and support devices in the future. Increasing cases of occupational injuries and road accidents are further expected to result in appreciable revenue growth in the orthopedic device market during the forecast period (2025-2032).

4. Who are the key players operating in Global Orthopedic Devices Market?

Some of the key market players operating in the orthopedic devices market include Stryker Corporation, Zimmer Biomet, Johnson and Johnson, Enovis, Smith & Nephew PLC, Medtronic PLC, Boston Scientific Corporation, NuVasive Inc., Globus Medical Inc., ConMed Corporation, Bioventus, Orthofix, Colson Medical LLC, Exactech Inc., Medacta International, Surgalign Holdings, Paragon 28 Inc, Orthofix, Arthrex Inc., Integra Lifesciences, Bosch Global, and others.

5. Which region has the highest share in the Orthopedic Devices market?

North America is expected to dominate the overall Orthopedic device market during the forecast period, 2025 to 2032. This can be ascribed to the presence of a large old age population in the North American region. Increasing cases of bone disorders like osteoarthritis and osteoporosis and weak skeletal system also do play a major role in driving the orthopedic device market in the region. In addition, it is a highly potent market in terms of product development and launches, and the presence of key market players also driving the market growth.